Product Information
ISRADIPINE 2.5 MG CAPSULE is a generic product labeled by Elite Laboratories, Inc., priced at $1.1368 per EA under NDC 64850091001. Its NADAC has been published 42 times since Dec 17, 2025.
FDA first approved this application on Apr 24, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5 mg/1
Manufacturer
Elite Laboratories, Inc.NDC
64850091001
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ISRADIPINEApproval Type
Generic (ANDA)
FDA Application
ANDA077169FDA Approved
4/24/2006
TE Code
AB
On Market Since
12/28/2022
Pharmacological Classes
Price Statistics
The NADAC for ISRADIPINE 2.5 MG CAPSULE has been published 42 times since Dec 17, 2025, and over the history we have for it it has declined 37.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1368 per EA |
|---|---|
| All-time high | $1.8070 (Jan 14, 2026) |
| All-time low | $1.1368 (Sep 23, 2026) |
| 52-week high | $1.8070 |
| 52-week low | $1.1368 |
| Median price | $1.7285 |
| Average price | $1.5878 |
| Largest weekly change | -17.6% (Aug 19, 2026) |
| Weeks tracked | 42 |
| Tracking since | Dec 17, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Elite Laboratories, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Isradipine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Dihydropyridine Calcium Channel Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ISRADIPINE 2.5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ISRADIPINE 2.5 MG CAPSULE, manufactured by Elite Laboratories, Inc., is $1.1368 per EA (NDC 64850091001), effective Sep 30, 2026.
How has the price of ISRADIPINE 2.5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for ISRADIPINE 2.5 MG CAPSULE has declined 37.1%. It has been tracked across 42 weekly CMS publications since Dec 17, 2025.
What are the highest and lowest recorded NADAC prices for ISRADIPINE 2.5 MG CAPSULE?
Since Dec 17, 2025, the NADAC for ISRADIPINE 2.5 MG CAPSULE has ranged from a low of $1.1368 (Sep 23, 2026) to a high of $1.8070 (Jan 14, 2026), with a median of $1.7285 per EA.
Are there cheaper alternatives to ISRADIPINE 2.5 MG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ISRADIPINE 2.5 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures ISRADIPINE 2.5 MG CAPSULE?
ISRADIPINE 2.5 MG CAPSULE (NDC 64850091001) is labeled by Elite Laboratories, Inc., and CMS classifies it as a generic product.